These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22043956)

  • 1. Developments in virus-like particle-based vaccines for infectious diseases and cancer.
    Buonaguro L; Tagliamonte M; Tornesello ML; Buonaguro FM
    Expert Rev Vaccines; 2011 Nov; 10(11):1569-83. PubMed ID: 22043956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developments in virus-like particle-based vaccines for HIV.
    Buonaguro L; Tagliamonte M; Visciano ML; Tornesello ML; Buonaguro FM
    Expert Rev Vaccines; 2013 Feb; 12(2):119-27. PubMed ID: 23414404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic approaches for the induction of a CD4+ T cell response in cancer immunotherapy.
    Bonehill A; Heirman C; Thielemans K
    J Gene Med; 2005 Jun; 7(6):686-95. PubMed ID: 15693037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell immunity generated by recombinant adenovirus vaccines.
    Yang TC; Millar JB; Grinshtein N; Bassett J; Finn J; Bramson JL
    Expert Rev Vaccines; 2007 Jun; 6(3):347-56. PubMed ID: 17542750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response.
    Flanagan K; Glover RT; Hörig H; Yang W; Kaufman HL
    Vaccine; 2004 Jul; 22(21-22):2894-903. PubMed ID: 15246626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of a foreign epitope on infectious pancreatic necrosis virus VP2 capsid protein subviral particle (SVP) and immunogenicity in rainbow trout.
    Dhar AK; Bowers RM; Rowe CG; Allnutt FC
    Antiviral Res; 2010 Mar; 85(3):525-31. PubMed ID: 20060858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
    Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH
    Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of human CD4+ and CD8+ T lymphocyte responses in experimental viral vaccine studies.
    Rothman AL; Yamada Y; Jameson J; Cruz J; West K; Green S; Ennis FA
    Dev Biol Stand; 1998; 95():95-104. PubMed ID: 9855419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class II-restricted tumor antigens recognized by CD4+ T cells: new strategies for cancer vaccine design.
    Zeng G
    J Immunother; 2001; 24(3):195-204. PubMed ID: 11394496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance of CD8(+) T-cell memory following infection with recombinant sindbis and vaccinia viruses.
    Villacres MC; Zuo J; Bergmann CC
    Virology; 2000 Apr; 270(1):54-64. PubMed ID: 10772979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.
    Fotin-Mleczek M; Duchardt KM; Lorenz C; Pfeiffer R; Ojkić-Zrna S; Probst J; Kallen KJ
    J Immunother; 2011 Jan; 34(1):1-15. PubMed ID: 21150709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant adenovirus vaccines can successfully elicit CD8+ T cell immunity under conditions of extreme leukopenia.
    Grinshtein N; Yang TC; Parsons R; Millar J; Denisova G; Dissanayake D; Leitch J; Wan Y; Bramson J
    Mol Ther; 2006 Feb; 13(2):270-9. PubMed ID: 16297666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
    Gómez CE; Abaitua F; Rodríguez D; Esteban M
    Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress toward an artificial vaccine for HIV: identification of helper and cytotoxic T-cell epitopes and methods of immunization.
    Berzofsky JA
    Biotechnol Ther; 1991; 2(1-2):123-35. PubMed ID: 1726961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient antitumor immunity in a murine colorectal cancer model induced by CEA RNA-electroporated B cells.
    Park MY; Kim HS; Woo SJ; Kim CH; Park JS; Sohn HJ; Kim HJ; Oh ST; Kim TG
    Eur J Immunol; 2008 Aug; 38(8):2106-17. PubMed ID: 18624349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-like particles: a new family of delivery systems.
    Boisgérault F; Morón G; Leclerc C
    Expert Rev Vaccines; 2002 Jun; 1(1):101-9. PubMed ID: 12908517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma antigens recognised by CD8+ and CD4+ T cells.
    Storkus WJ; Zarour HM
    Forum (Genova); 2000; 10(3):256-70. PubMed ID: 11007933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The virosome concept for influenza vaccines.
    Huckriede A; Bungener L; Stegmann T; Daemen T; Medema J; Palache AM; Wilschut J
    Vaccine; 2005 Jul; 23 Suppl 1():S26-38. PubMed ID: 16026906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lentivector immunization induces tumor antigen-specific B and T cell responses in vivo.
    Garcia Casado J; Janda J; Wei J; Chapatte L; Colombetti S; Alves P; Ritter G; Ayyoub M; Valmori D; Chen W; Lévy F
    Eur J Immunol; 2008 Jul; 38(7):1867-76. PubMed ID: 18546142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination against lymphocytic choriomeningitis virus infection in MHC class II-deficient mice.
    Holst PJ; Christensen JP; Thomsen AR
    J Immunol; 2011 Apr; 186(7):3997-4007. PubMed ID: 21357263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.